DAKLOS P
DICLOFENCE POTTASSIUM 50 MG + PARACETAMOL 325 MG TABS
Brand: DAKLOS P
MRP
₹475/-
Packaging
20*10 BLISTER
Form
Tablets
Description & Usage
Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs
Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs is a tablet formulation with the combination of Diclofenac Potassium and Paracetamol. In the general medicine and pain management segment, this composition is having a solid grip. The combination of both has earned the product a professional formulation and the composition is an asset for any pharmaceutical business house.
This formulation as a tablet commonly becomes part of the business module of PCD pharma franchise companies, third-party manufacturers, branded marketers and distributors. Its nature as a tablet helps in easy packaging, storage, transit and supply to various market levels through different distribution channels. Well-prepared and properly packaged, this Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs can be a great value addition to a strong portfolio.
Composition Profile And Tablet Strength
Each tablet in the pack has Diclofenac Potassium 50 mg and Paracetamol 325 mg as its chief formulation ingredients. Diclofenac Potassium a commonly found active pharmaceutical ingredient while Paracetamol perhaps one of the most utilized APIs in the general medicine formulations. Combined together, the both form a very standard combination within the pharmaceutical market.
The preparation of this tablet requires excipients that help in developing an optimum hardness, stability, disintegration and also shape, shelf-life to the tablet formulation. When a particular tablet is formulated properly then the active ingredients, both Diclofenac Potassium and Paracetamol, are present in equal proportion in each unit which helps in achieving and maintaining consistency of products, thereby establishing an added reliability in the market.
The dosage strength as 50 mg for Diclofenac Potassium and 325 mg for Paracetamol, gives the product a specific market identity and it is ideally placed for the pharmaceutical business houses willing to achieve their comprehensive pain management and general medicine product divisions.
Quality Manufacturing And Standard Processing
Quality manufacturing and adherence to standard production practices for Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs are a very essential requirement. High-grade and pure raw materials are required while the machines used for manufacturing must be of a high standard. The factory should be maintained with adequate hygiene and under professional supervision so as to ensure maximum quality assurance for this product.
Quality control is performed at various stages of the manufacturing of such a formulation right from raw material testing, inspection of granulation, blending uniformity analysis, compression controls, variations in tablet weight, tablet hardness test, disintegration test for the tablet and at the finishing stage of all the product components before it gets packaged and ready for sale. For combination drugs like Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs, it is important that the blending of both actives is uniform.
Good manufacturing practice enables us to gain better quality control of all batches and increase product value in the marketplace. As a standard manufacturing practice, quality control is an important aspect, which builds a lot of trust between different stakeholders such as wholesalers, retailers, franchise partners etc.
Packaging, Labeling And Brand Presentation
Packaging ensures safety and hygiene of Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs and helps in improving the branding of the product in the market. These formulations can be found packaged in blisters, strips or Alu-Alu packaging as per the customer demands. Appropriate packaging helps in preserving the tablets against damage due to light, moisture, and environmental factors.
Labeling helps in the precise communication of information such as brand name, salt name, strengths, batch number, expiry date, M.R.P., storage guidelines, manufacturer details etc. A neat and professionally printed product with clear and readable text improves the reliability of the brand in the market.
Packaging is one of the effective brand-building strategies in the pharma domain. A well-designed strip design, proper carton display and clear depiction of the composition can always provide an added competitive advantage and thus help the company gain better brand recall and value in the market.
Market Demand And Business Importance
Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs has great demand in the pharma market as the combination formulation is frequently included in the product portfolios. Adding this formulation in one's list can be considered as a means to strengthening a firm's presence in the pain management category thereby enhancing the overall product portfolio.
The composition is an important product from a business point of view for wholesalers, distributors, retailers and PCD pharma franchise owners due to the regular market demand and is among the most common components that a firm adds to its product inventory. As such, it gives an advantage to have such products as they complement the overall pharma product range that a business house wishes to present to its customers. A robust product portfolio helps improve market reach and enhances business volume over time.
These Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs with the assurance of good manufacturing and proper packaging, and a commitment to prompt delivery would surely win the trust of the distributors, retailers, franchise partners, and can definitely prove beneficial to both new and established businesses looking forward to expand their existing range in the general medicine products category.
PCD Pharma Franchise Scope
The Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs offer significant scope in the PCD Pharma Franchise business. Being a regularly demanded product, with proper promotion, it can certainly capture a strong position in the target markets. Pharma companies engaged in PCD pharma franchise can present product cards, reminder cards, visual aid materials, prescription pads, MR bags and various other promotional inputs to their PCD distributors to better market and promote the products.
The combination is a beneficial product for franchise distributors. Any pharma company providing quality assurance, proper packing, monopoly business right, timely deliveries and an all-round support including sales promotion, can easily promote this product effectively in their allocated territory and create opportunities for business.
The Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs product due to its composition, presentation, tablet format, and market relevance provide a clear opportunity for PCD pharma companies.
Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs
Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs is a tablet formulation with the combination of Diclofenac Potassium and Paracetamol. In the general medicine and pain management segment, this composition is having a solid grip. The combination of both has earned the product a professional formulation and the composition is an asset for any pharmaceutical business house.
This formulation as a tablet commonly becomes part of the business module of PCD pharma franchise companies, third-party manufacturers, branded marketers and distributors. Its nature as a tablet helps in easy packaging, storage, transit and supply to various market levels through different distribution channels. Well-prepared and properly packaged, this Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs can be a great value addition to a strong portfolio.
Composition Profile And Tablet Strength
Each tablet in the pack has Diclofenac Potassium 50 mg and Paracetamol 325 mg as its chief formulation ingredients. Diclofenac Potassium a commonly found active pharmaceutical ingredient while Paracetamol perhaps one of the most utilized APIs in the general medicine formulations. Combined together, the both form a very standard combination within the pharmaceutical market.
The preparation of this tablet requires excipients that help in developing an optimum hardness, stability, disintegration and also shape, shelf-life to the tablet formulation. When a particular tablet is formulated properly then the active ingredients, both Diclofenac Potassium and Paracetamol, are present in equal proportion in each unit which helps in achieving and maintaining consistency of products, thereby establishing an added reliability in the market.
The dosage strength as 50 mg for Diclofenac Potassium and 325 mg for Paracetamol, gives the product a specific market identity and it is ideally placed for the pharmaceutical business houses willing to achieve their comprehensive pain management and general medicine product divisions.
Quality Manufacturing And Standard Processing
Quality manufacturing and adherence to standard production practices for Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs are a very essential requirement. High-grade and pure raw materials are required while the machines used for manufacturing must be of a high standard. The factory should be maintained with adequate hygiene and under professional supervision so as to ensure maximum quality assurance for this product.
Quality control is performed at various stages of the manufacturing of such a formulation right from raw material testing, inspection of granulation, blending uniformity analysis, compression controls, variations in tablet weight, tablet hardness test, disintegration test for the tablet and at the finishing stage of all the product components before it gets packaged and ready for sale. For combination drugs like Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs, it is important that the blending of both actives is uniform.
Good manufacturing practice enables us to gain better quality control of all batches and increase product value in the marketplace. As a standard manufacturing practice, quality control is an important aspect, which builds a lot of trust between different stakeholders such as wholesalers, retailers, franchise partners etc.
Packaging, Labeling And Brand Presentation
Packaging ensures safety and hygiene of Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs and helps in improving the branding of the product in the market. These formulations can be found packaged in blisters, strips or Alu-Alu packaging as per the customer demands. Appropriate packaging helps in preserving the tablets against damage due to light, moisture, and environmental factors.
Labeling helps in the precise communication of information such as brand name, salt name, strengths, batch number, expiry date, M.R.P., storage guidelines, manufacturer details etc. A neat and professionally printed product with clear and readable text improves the reliability of the brand in the market.
Packaging is one of the effective brand-building strategies in the pharma domain. A well-designed strip design, proper carton display and clear depiction of the composition can always provide an added competitive advantage and thus help the company gain better brand recall and value in the market.
Market Demand And Business Importance
Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs has great demand in the pharma market as the combination formulation is frequently included in the product portfolios. Adding this formulation in one's list can be considered as a means to strengthening a firm's presence in the pain management category thereby enhancing the overall product portfolio.
The composition is an important product from a business point of view for wholesalers, distributors, retailers and PCD pharma franchise owners due to the regular market demand and is among the most common components that a firm adds to its product inventory. As such, it gives an advantage to have such products as they complement the overall pharma product range that a business house wishes to present to its customers. A robust product portfolio helps improve market reach and enhances business volume over time.
These Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs with the assurance of good manufacturing and proper packaging, and a commitment to prompt delivery would surely win the trust of the distributors, retailers, franchise partners, and can definitely prove beneficial to both new and established businesses looking forward to expand their existing range in the general medicine products category.
PCD Pharma Franchise Scope
The Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs offer significant scope in the PCD Pharma Franchise business. Being a regularly demanded product, with proper promotion, it can certainly capture a strong position in the target markets. Pharma companies engaged in PCD pharma franchise can present product cards, reminder cards, visual aid materials, prescription pads, MR bags and various other promotional inputs to their PCD distributors to better market and promote the products.
The combination is a beneficial product for franchise distributors. Any pharma company providing quality assurance, proper packing, monopoly business right, timely deliveries and an all-round support including sales promotion, can easily promote this product effectively in their allocated territory and create opportunities for business.
The Diclofenac Potassium 50 MG + Paracetamol 325 MG Tabs product due to its composition, presentation, tablet format, and market relevance provide a clear opportunity for PCD pharma companies.